NCT05630183Phase 2Completed

A Study of Botensilimab in Participants With Metastatic Pancreatic Cancer

Study sponsor: Agenus Inc. · AGEN

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-01-05Actual
Enrollment · participants81Actual
Source updated2026-06-11Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 3 fields changed

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: 5 Dec 2025. After: 5 Jan 2026.

Recruitment status changed

Before: Active not recruiting. After: Completed.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview